Otilimab - CAS 1638332-55-4

Otilimab (GSK 3196165) is a humanized monoclonal antibody against granulocyt-macrophage colony-stimulating factor (GM-CSF) . Otilimab has anti-inflammatory activity, regulates the biological function of GM-CSF by blocking the interaction between GM-CSF and its cell surface receptors, and can be used in studies to treat severe COVID-19 pneumonia.

C-Fms, CSF-1R

Tyrosine Kinase/Adaptors

1638273

>95%

-20°C

Ice Packs

Inhibitory Antibodies